TY - JOUR
T1 - Agonist-induced sorting of human β2-adrenergic receptors to lysosomes during downregulation
AU - Moore, Robert H.
AU - Tuffaha, Amjad
AU - Millman, Ellen E.
AU - Dai, Wenping
AU - Hall, Hassan S.
AU - Dickey, Burton F.
AU - Knoll, Brian J.
PY - 1999
Y1 - 1999
N2 - During prolonged exposure to agonist, β2-adrenergic receptors undergo downregulation, defined by the loss of radioligand binding sites. To determine the cellular basis for β2-adrenergic receptor downregulation, we examined HEK293 cells stably expressing β2-adrenergic receptors with an N-terminal epitope tag. Downregulation was blocked by leupeptin, a cysteine protease inhibitor, but not by pepstatin, an inhibitor of aspartate proteases. Immunofluorescence microscopy of cells treated with agonist for 3-6 hours in the presence of leupeptin showed β2-adrenergic receptors, but not transferrin receptors, localizing with the lysosomal protease cathepsin D, and with lysosomes labeled by uptake of a fluorescent fluid-phase marker. No localization of β2-adrenergic receptors with lysosomal markers was observed in the absence of leupeptin, most likely due to proteolysis of the epitope. The proton pump inhibitor, bafilomycin A1, significantly inhibited this agonist-induced redistribution of β2-adrenergic receptors into lysosomes, causing receptors to accumulate in the rab11-positive perinuclear recycling compartment and slowing the rate of β2-adrenergic receptor recycling. Control experiments showed that leupeptin had no nonspecific effects on the cellular trafficking of either β2-adrenergic receptors or transferrin receptors. Although cAMP alone caused a small decline in receptor levels without redistributing β2-adrenergic receptors from the plasma membrane, this effect was additive to that seen with agonist alone, suggesting that agonist-induced β2-adrenergic receptor downregulation resulted largely from cAMP-independent mechanisms. These results indicate that during agonist-induced downregulation, a significant fraction of β2-adrenergic receptors are specifically sorted to lysosomes via the endosomal pathway, where receptor degradation by cysteine proteases occurs. These results provide a cellular explanation for the loss of radioligand binding sites that occurs during prolonged exposure to agonist.
AB - During prolonged exposure to agonist, β2-adrenergic receptors undergo downregulation, defined by the loss of radioligand binding sites. To determine the cellular basis for β2-adrenergic receptor downregulation, we examined HEK293 cells stably expressing β2-adrenergic receptors with an N-terminal epitope tag. Downregulation was blocked by leupeptin, a cysteine protease inhibitor, but not by pepstatin, an inhibitor of aspartate proteases. Immunofluorescence microscopy of cells treated with agonist for 3-6 hours in the presence of leupeptin showed β2-adrenergic receptors, but not transferrin receptors, localizing with the lysosomal protease cathepsin D, and with lysosomes labeled by uptake of a fluorescent fluid-phase marker. No localization of β2-adrenergic receptors with lysosomal markers was observed in the absence of leupeptin, most likely due to proteolysis of the epitope. The proton pump inhibitor, bafilomycin A1, significantly inhibited this agonist-induced redistribution of β2-adrenergic receptors into lysosomes, causing receptors to accumulate in the rab11-positive perinuclear recycling compartment and slowing the rate of β2-adrenergic receptor recycling. Control experiments showed that leupeptin had no nonspecific effects on the cellular trafficking of either β2-adrenergic receptors or transferrin receptors. Although cAMP alone caused a small decline in receptor levels without redistributing β2-adrenergic receptors from the plasma membrane, this effect was additive to that seen with agonist alone, suggesting that agonist-induced β2-adrenergic receptor downregulation resulted largely from cAMP-independent mechanisms. These results indicate that during agonist-induced downregulation, a significant fraction of β2-adrenergic receptors are specifically sorted to lysosomes via the endosomal pathway, where receptor degradation by cysteine proteases occurs. These results provide a cellular explanation for the loss of radioligand binding sites that occurs during prolonged exposure to agonist.
KW - Bafilomycin A
KW - Downregulation
KW - Laser confocal microscopy
KW - Lysosome
KW - rab11
KW - β-adrenergic receptor
UR - http://www.scopus.com/inward/record.url?scp=0033036546&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033036546&partnerID=8YFLogxK
M3 - Article
C2 - 9885286
AN - SCOPUS:0033036546
SN - 0021-9533
VL - 112
SP - 329
EP - 338
JO - Journal of cell science
JF - Journal of cell science
IS - 3
ER -